A first participant was dosed at I-Motion, the pediatric clinical
Vaccine candidate containing tetanus toxoid potentially protective against SARS-CoV-2
Researchers from Cuba, China, and France have demonstrated the potential
Lundquist Institute receives grant to evaluate safety, efficacy of compound for treating psychological distress
The Lundquist Institute has received a $1.75 million grant from
Gene Targets for in Utero Therapy in Down Syndrome: Potentials and Pitfalls
By Keynote ContributorProf. Ahmad Salehi, M.D, Ph.DClinical Professor with Stanford